| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |